Cedars Sinai


 

SGLT2 Inhibitors: Are They the Modern-Day Statins? Insights from Recent Cardiorenal Metabolic Outcome Trial

1,784 views
February 7, 2022
2 Comments
Login to view comments. Click here to Login
Controversies and Advances in the Treatment of Cardiovascular Disease: The Twentieth in the Series